{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:00Z","timestamp":1761468900389,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.transci.2021.103071","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:49:57Z","timestamp":1611748197000},"page":"103071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review"],"prefix":"10.1016","volume":"60","author":[{"given":"Daniele","family":"Focosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-0580","authenticated-orcid":false,"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103071_bib0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","volume":"49","author":"Peeri","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.transci.2021.103071_bib0010","doi-asserted-by":"crossref","first-page":"m1036","DOI":"10.1136\/bmj.m1036","article-title":"Covid-19: WHO declares pandemic because of \u201calarming levels\u201d of spread, severity, and inaction","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2021.103071_bib0015","article-title":"Novel corona virus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments","author":"Boban","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.transci.2021.103071_bib0020","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41467-020-19056-6","article-title":"A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics","volume":"11","author":"Lyngbakken","year":"2020","journal-title":"Nat Commun"},{"issue":"10236","key":"10.1016\/j.transci.2021.103071_bib0025","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2021.103071_bib0030","article-title":"Repurposed antiviral drugs for COVID-19 \u2013interim WHO SOLIDARITY trial results","author":"WHO Solidarity trial consortium","year":"2020","journal-title":"medRxiv"},{"issue":"16","key":"10.1016\/j.transci.2021.103071_bib0035","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2021.103071_bib0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nature Microbiol Rev"},{"issue":"2","key":"10.1016\/j.transci.2021.103071_bib0045","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2021.103071_bib0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejim.2020.05.019","article-title":"Why should we use convalescent plasma for COVID-19?","volume":"77","author":"Franchini","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.transci.2021.103071_bib0055","article-title":"Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial","author":"Perotti","year":"2020","journal-title":"Haematologica"},{"issue":"17","key":"10.1016\/j.transci.2021.103071_bib0060","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.transci.2021.103071_bib0065","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2020007079","article-title":"Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion","volume":"136","author":"Xia","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.transci.2021.103071_bib0070","first-page":"CD013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"10","author":"Chai","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.transci.2021.103071_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2021.103071_bib0080","article-title":"COVID-19 convalescent plasma therapy: hit fast, hit hard!","author":"Focosi","year":"2020","journal-title":"Vox Sang"},{"issue":"22","key":"10.1016\/j.transci.2021.103071_bib0085","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1002\/cam4.3457","article-title":"Convalescent plasma for the treatment of severe COVID-19 infection in cancer patients","volume":"9","author":"Tremblay","year":"2020","journal-title":"Cancer Med"},{"issue":"20","key":"10.1016\/j.transci.2021.103071_bib0090","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2020008423","article-title":"Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19","volume":"136","author":"Hueso","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.transci.2021.103071_bib0095","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case Study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.transci.2021.103071_bib0100","first-page":"e9629","article-title":"Concurrent diagnosis of acute myeloid leukemia and COVID-19: a management challenge","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.transci.2021.103071_bib0105","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.transci.2020.102821","article-title":"Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis","volume":"59","author":"\u00c7\u0131nar","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103071_bib0110","article-title":"Treatment of immunocompromised COVID-19 patients with convalescent plasma","author":"Fung","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transci.2021.103071_bib0115","article-title":"Convalescent plasma rescued a severe COVID-19 patient with chronic myeloid leukemia blast crisis and myelofibrosis","author":"Zhang","year":"2020","journal-title":"Turk J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2021.103071_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-020-00968-1","article-title":"Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia","volume":"13","author":"Lancman","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"19","key":"10.1016\/j.transci.2021.103071_bib0125","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1182\/bloodadvances.2020002595","article-title":"Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19","volume":"4","author":"Luetkens","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.transci.2021.103071_bib0130","doi-asserted-by":"crossref","first-page":"102871","DOI":"10.1016\/j.transci.2020.102871","article-title":"Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma","volume":"59","author":"Karata\u015f","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103071_bib0135","article-title":"Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma","author":"Wright","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.transci.2021.103071_bib0140","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1111\/bjh.16981","article-title":"Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery","volume":"190","author":"Clark","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2021.103071_bib0145","article-title":"Prolonged SARS-CoV-2 replication in an immunocompromised patient","author":"Baang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transci.2021.103071_bib0150","article-title":"Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19","author":"Malsy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2021.103071_bib0155","article-title":"Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies","author":"Betrains","year":"2020","journal-title":"Br J Haematol"},{"issue":"October (21)","key":"10.1016\/j.transci.2021.103071_bib0160","article-title":"A 63-Year-Old woman with a history of non-Hodgkin lymphoma with persistent SARS-CoV-2 infection who was seronegative and treated with convalescent plasma","volume":"3","author":"Moore","year":"2020","journal-title":"Am J Case Rep"},{"issue":"5","key":"10.1016\/j.transci.2021.103071_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102866","article-title":"First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia","volume":"59","author":"Figlerowicz","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.transci.2021.103071_bib0170","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/bjh.16852","article-title":"Clinical outcome of coronavirus disease 2019 in haemato-oncology patients","volume":"190","author":"Aries","year":"2020","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transci.2021.103071_bib0175","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transci.2021.103071_bib0180","article-title":"Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency","author":"Senefeld","year":"2020","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.transci.2021.103071_bib0185","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3855\/jidc.13840","article-title":"Atypical course of COVID-19 in patient with Bruton agammaglobulinemia","volume":"14","author":"Milo\u0161evi\u0107","year":"2020","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"10.1016\/j.transci.2021.103071_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.08.059","article-title":"Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma","volume":"8","author":"Jin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.transci.2021.103071_bib0195","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.jaip.2020.06.046","article-title":"Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma","volume":"8","author":"Mira","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.transci.2021.103071_bib0200","first-page":"1","article-title":"Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy","author":"London","year":"2020","journal-title":"J Clin Immunol"},{"issue":"November (11)","key":"10.1016\/j.transci.2021.103071_bib0205","doi-asserted-by":"crossref","first-page":"596761","DOI":"10.3389\/fimmu.2020.596761","article-title":"Case Report: convalescent plasma, a targeted therapy for patients with COVID and severe COVID-19","volume":"20","author":"Van Damme","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2021.103071_bib0210","article-title":"COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature","volume":"2020","author":"Aksoy","year":"2020","journal-title":"Case Rep Infect Dis"},{"issue":"10","key":"10.1016\/j.transci.2021.103071_bib0215","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID-19 patients in Wuhan, China","volume":"92","author":"Ye","year":"2020","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.transci.2021.103071_bib0220","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jinf.2020.04.026","article-title":"How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review","volume":"81","author":"Minotti","year":"2020","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.transci.2021.103071_bib0225","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/ajt.15874","article-title":"Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","volume":"20","author":"Guillen","year":"2020","journal-title":"Am J Transplant"},{"issue":"August","key":"10.1016\/j.transci.2021.103071_bib0230","article-title":"UW COVID-19 SOT study team. COVID-19 in solid organ transplant: a multi-center cohort study","author":"Kates","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.transci.2021.103071_bib0235","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transci.2021.103071_bib0240","first-page":"102983","article-title":"SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation","author":"Balashov","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.transci.2021.103071_bib0245","doi-asserted-by":"crossref","first-page":"102871","DOI":"10.1016\/j.transci.2020.102871","article-title":"Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma","volume":"59","author":"Karata\u015f","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103071_bib0250","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14089","article-title":"Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: experience at large transplant center in New York City","author":"Rahman","year":"2020","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.transci.2021.103071_bib0255","doi-asserted-by":"crossref","first-page":"526","DOI":"10.14701\/ahbps.2020.24.4.526","article-title":"Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia","volume":"24","author":"Jamir","year":"2020","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"5","key":"10.1016\/j.transci.2021.103071_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13382","article-title":"COVID-19 in recent heart transplant recipients: clinicopathologic features and early outcomes","volume":"22","author":"Lima","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transci.2021.103071_bib0265","article-title":"Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy","author":"Naeem","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.transci.2021.103071_bib0270","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14025","article-title":"Convalescent plasma therapy: helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications","volume":"34","author":"Jiang","year":"2020","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.transci.2021.103071_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2020.100588","article-title":"COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature","volume":"35","author":"Raja","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"year":"2020","series-title":"One of the first COVID-19 convalescent plasma recipients supports donor appeal","author":"NHS Blood and Transplant","key":"10.1016\/j.transci.2021.103071_bib0280"},{"key":"10.1016\/j.transci.2021.103071_bib0285","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2021.103071_bib0290","article-title":"Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion","author":"Kemp","year":"2020","journal-title":"medRxiv"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:09Z","timestamp":1761468669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1473050221000215"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103071","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103071"}}